All Stories

  1. Free Thyroxine Concentrations in Sera of Individuals with Familial Dysalbuminemic Hyperthyroxinemia: A Comparison of Three Methods of Measurement
  2. Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes
  3. Detection of Insulin-Like Growth Factor 1 Variants by Mass Spectrometry: Results from a Clinical Reference Laboratory
  4. Plasma Free Cortisol in States of Normal and Altered Binding Globulins: Implications for Adrenal Insufficiency Diagnosis
  5. Adrenal insufficiency in neonates undergoing cardiopulmonary bypass and postoperative hypothalamic-pituitary-adrenal function after prophylactic glucocorticoids
  6. The relationship between IGF-I and -II concentrations and body composition at birth and over the first 2 months
  7. Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a multiethnic cohort of patients with type 2 diabetes mellitus
  8. Insulin Resistance Probability Scores for Apparently Healthy Individuals
  9. Elevated Hemoglobin A1cIs Associated With Incident Diabetes Within 4 Years Among Normoglycemic, Working-Age Individuals in an Employee Wellness Program
  10. Use of a metabolomic approach to non-invasively diagnose non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus
  11. Another Look at Hereditary Partial Androgen Insensitivity Syndrome in an Indigenous Community in the Northern Territory of Australia
  12. Prediction of Type 2 Diabetes by Hemoglobin A 1c in Two Community-Based Cohorts
  13. Identification of the Underlying Androgen Receptor Defect in the Dallas Reifenstein Family
  14. Quantitative Amino Acid Analysis in Insulin and C-Peptide Assays
  15. A high-throughput mass spectrometry assay to simultaneously measure intact insulin and C-peptide
  16. Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD
  17. Androgen Insensitivity Due to Mutations of the Androgen Receptor
  18. RelaunchingJIM
  19. Plasma Renin Activity: The Importance of Correct Sample Type
  20. Surge in Newly Identified Diabetes Among Medicaid Patients in 2014 Within Medicaid Expansion States Under the Affordable Care Act
  21. Mifepristone (RU-486) in the Treatment of Refractory Cushing's Disease.
  22. Physiology of Testicular Steroidogenesis
  23. Issues in Developing the Medical Scientist, Part 2: Fostering Research among Medical Students (Interview with Michael John McPhaul, MD)
  24. Doris Duke Clinical Research Fellowship: Report of the Second Annual Meeting
  25. Androgen Receptor-Related Pathology
  26. Alterations of Androgen Action Caused by Mutation of the Human Androgen Receptor
  27. Androgen receptor mutations and androgen insensitivity
  28. Molecular Defects of the Androgen Receptor
  29. Expression of the human androgen receptor in eukaryotic cells using a recombinant adenovirus vector yields high levels of the soluble, functional receptor protein
  30. Complexities of androgen action
  31. The Androgen Receptor, Androgen Insensitivity, and Prostate Cancer
  32. Molecular defects of the androgen receptor
  33. Genetic Alterations of Androgen Receptor Function
  34. Identification of genes expressed in the rat prostate that are modulated differently by castration and Finasteride treatment
  35. Regulation of Reproduction
  36. Defects of Androgen Action
  37. Amino acid substitutions in the hormone-binding domain of the human androgen receptor alter the stability of the hormone receptor complex.
  38. 8 Androgen insensitivity syndrome
  39. MUTATIONS IN THE ANDROGEN RECEPTOR GENE CAUSING ANDROGEN RESISTANCE
  40. Immunoreactive androgen receptor expression in subjects with androgen resistance.
  41. Molecular Defects in the Androgen Receptor Causing Androgen Resistance
  42. Amino acid substitutions in the DNA-binding domain of the human androgen receptor are a frequent cause of receptor-binding positive androgen resistance.
  43. Molecular basis of androgen resistance
  44. Androgen resistance caused by mutations in the androgen receptor gene.
  45. Androgen Resistance Associated with a Mutation of the Androgen Receptor at Amino Acid 772 (Arg→Cys) Results from a Combination of Decreased Messenger Ribonucleic Acid Levels and Impairment of Receptor Function*
  46. Molecular basis of androgen resistance in a family with a qualitative abnormality of the androgen receptor and responsive to high-dose androgen therapy.
  47. A mutation in the DNA-binding domain of the androgen receptor gene causes complete testicular feminization in a patient with receptor-positive androgen resistance.
  48. Structure and Expression of the Androgen Receptor in Normal Tissues and in Prostate Carcinoma Cell Lines
  49. Definition of the Human Androgen Receptor Gene Structure Permits the Identification of Mutations that Cause Androgen Resistance: Premature Termination of the Receptor Protein at Amino Acid Residue 588 Causes Complete Androgen Resistance
  50. Antipeptide Antibodies to Two Distinct Regions of the Androgen Receptor Localize the Receptor Protein to the Nuclei of Target Cells in the Rat and Human Prostate*
  51. A single nucleotide substitution introduces a premature termination codon into the androgen receptor gene of a patient with receptor-negative androgen resistance.
  52. Recent studies of the androgen receptor: new insights into old questions
  53. Characterization and expression of a cDNA encoding the human androgen receptor.
  54. Snuff-Induced Hypertension in Pheochromocytoma
  55. Snuff-induced hypertension in pheochromocytoma
  56. Polyphosphino macrocyclic ligand systems
  57. Defects of Androgen Action
  58. Mechanisms of Hormone Action
  59. The Androgen Receptor, Androgen Insensitivity, and Prostate Cancer
  60. Alterations of Androgen Action Caused by Mutation of the Human Androgen Receptor